Determinants of Overall Survival in Metastatic Uveal Melanoma Identified
Female sex, anti-CTLA‐4 therapy, and anti-PD‐1 therapy linked to better overall survival, while worse survival seen with hepatic metastases
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.